0 Комментарии
0 Поделились
157 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Beta Catenin Market to Hit USD ~ 5,646.76 B by 2032; Rapid Growth Driven by Oncology and Regenerative Medicine ApplicationsThe global Beta Catenin market is poised for dramatic expansion through the coming decade, with market valuation expected to grow from approximately USD 2,495.01 million in 2023 to around USD 5,646.76 million by 2032, reflecting a compound annual growth rate (CAGR) of ~9.5% between 2024 and 2032, according to the newly published Beta Catenin Market Report by Introspective Market Research. The...0 Комментарии 0 Поделились 157 Просмотры 0 предпросмотр
-
Beta Catenin Market to Hit USD ~ 5,646.76 B by 2032; Rapid Growth Driven by Oncology and Regenerative Medicine ApplicationsThe global Beta Catenin market is poised for dramatic expansion through the coming decade, with market valuation expected to grow from approximately USD 2,495.01 million in 2023 to around USD 5,646.76 million by 2032, reflecting a compound annual growth rate (CAGR) of ~9.5% between 2024 and 2032, according to the newly published Beta Catenin Market Report by Introspective Market Research. The...0 Комментарии 0 Поделились 156 Просмотры 0 предпросмотр1
-
Beta-thalassemia (B-thal) Market - Latest Advancement And Industry AnalysisBeta-Thalassemia (B-thal) Market Poised to Nearly Double by 2032 From USD 8.34 B in 2023 to USD 16.95 B Surging prevalence, gene-therapy breakthroughs and rising rare-disease funding to fuel 8.2% CAGR through 2032 The global Beta-thalassemia (B-thal) market is on track to almost double in size over the next decade. Valued at USD 8.34 billion in 2023, the market is projected to reach USD 16.95...0 Комментарии 0 Поделились 147 Просмотры 0 предпросмотр
-
Beta-thalassemia (B-thal) Market - Latest Advancement And Industry AnalysisBeta-Thalassemia (B-thal) Market Poised to Nearly Double by 2032 From USD 8.34 B in 2023 to USD 16.95 B Surging prevalence, gene-therapy breakthroughs and rising rare-disease funding to fuel 8.2% CAGR through 2032 The global Beta-thalassemia (B-thal) market is on track to almost double in size over the next decade. Valued at USD 8.34 billion in 2023, the market is projected to reach USD 16.95...0 Комментарии 0 Поделились 147 Просмотры 0 предпросмотр
-
Beta-thalassemia (B-thal) Market - Latest Advancement And Industry AnalysisBeta-Thalassemia (B-thal) Market Poised to Nearly Double by 2032 From USD 8.34 B in 2023 to USD 16.95 B Surging prevalence, gene-therapy breakthroughs and rising rare-disease funding to fuel 8.2% CAGR through 2032 The global Beta-thalassemia (B-thal) market is on track to almost double in size over the next decade. Valued at USD 8.34 billion in 2023, the market is projected to reach USD 16.95...0 Комментарии 0 Поделились 152 Просмотры 0 предпросмотр